{
  "id": 12383173,
  "title": "Proposed nuclear safety rules threaten to stall Novartis’ Pluvicto expansion",
  "url": "https://urgent.news/2026/10/06/proposed-nuclear-safety-rules-threaten-to-stall-novartis-pluvicto",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T11:24:39.000Z",
  "source": {
    "name": "Fierce Healthcare",
    "slug": "fierce-healthcare",
    "url": "https://www.fiercehealthcare.com/pharma/proposed-nuclear-safety-rules-threaten-stall-novartis-pluvicto-expansion"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novartis’ flagship radioligand therapy Pluvicto entered a rapid growth phase recently, driven by FDA approvals in earlier-stage prostate cancer and broader uptake in community settings. But a regulatory overhaul proposed by federal nuclear authorities now threatens to derail that momentum, potentially raising administrative hurdles that experts say could force clinics to rethink patient care…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}